entertainment -WSS

entertainment

author：comprehensive 2025-09-29 13:09:52 - browse：88

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Annovis Bio delivers candor, but not confidence, on Parkinson’s study

focus

WSS

With competition flaring, obesity drug hits goal in liver disease study

Cigna to pay $172 million to settle Medicare Advantage fraud probe

How one patient went off dialysis — and others can too

PBM reform efforts get punted in Congress

Community Health Systems hospitals under DOJ investigation

Would Medicare drug price negotiations stall in a shutdown?

Wikipedia

entertainment

focus

ChatGPT in medicine: STAT answers readers' burning questions

Biogen shutters digital health group, ends Apple study, in cost cutting move

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Why palliative psychiatry is worth discussing

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A new nitrogen execution bill also undermines medical licensing

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Community Health Systems hospitals under DOJ investigation

Wildfire smoke exposes gaps in outdoor worker protections

A solution to the after

leisure time

He's a Nobel laureate. Critics say he was misleading on Covid

How one patient went off dialysis — and others can too

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

A solution to the after

Antivenom research: Lessons from HIV applied in search for universal antidote

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

hotspot

focus

focus

hotspot